PharmaShots | Incisive News in 3 Shots

Subscribe Now

Short Bowel Syndrome

Zealand Pharma Submits an NDA for Glepaglutide to the US FDA for the Treatment of Short Bowel Syndrome (SBS)

Zealand Pharma Submits an NDA for Glepaglutide to the US FDA for the Treatment of Short Bowel Syndrome (SBS)

December 26, 2023

Alcresta Therapeutics’ RELiZORB Digestive Enzyme Cartridge Receives the US FDA’s 510(k) Clearance

Alcresta Therapeutics’ RELiZORB Digestive Enzyme Cartridge Receives the US FDA’s 510(k) Clearance

December 23, 2023

Ironwood to Acquire VectivBio for ~$1B

Ironwood to Acquire VectivBio for ~$1B

May 23, 2023

Zealand Pharma Reports P-III (EASE 1) Trial Results of Glepaglutide for the Treatment of Short Bowel Syndrome

Zealand Pharma Reports P-III (EASE 1) Trial Results of Glepaglutide for the Treatment of Short Bowel Syndrome

September 30, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us